IC
PRME icon

IEQ Capital’s Prime Medicine PRME Stock Holding History

IEQ Capital’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.9K Sell
16,503
-57,510
-78% -$191K ﹤0.01% 1976
2026
Q1 		$258K Buy
74,013
+36,877
+99% +$140K ﹤0.01% 1585
2025
Q4 		$129K Buy
37,136
+469
+1% +$2.09K ﹤0.01% 1743
2025
Q3 		$203K Buy
36,667
+837
+2% +$3.4K ﹤0.01% 1681
2025
Q2 		$88.5K Buy
35,830
+948
+3% +$1.46K ﹤0.01% 1726
2025
Q1 		$69.4K Buy
+34,882
New +$89K ﹤0.01% 1526

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

IEQ Capital's PRME Position: Q2 2026 in Review

IEQ Capital reduced its Prime Medicine (PRME) stake by 78% in Q2 2026, selling an estimated $191K and leaving 16,503 shares worth $60.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1976.

IEQ Capital first reported a position in PRME in Q1 2025 and has held it in 6 quarters since. The position peaked at $258K in Q1 2026. 188 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • IEQ Capital held 16,503 shares of Prime Medicine worth $60.9K as of Q2 2026.
  • IEQ Capital sold 57,510 Prime Medicine shares in Q2 2026, an estimated $191K.
  • Prime Medicine made up ﹤0.01% of IEQ Capital's portfolio in Q2 2026, its #1976 holding.
  • IEQ Capital first reported a position in Prime Medicine in Q1 2025 and has held it in 6 quarters since.
  • IEQ Capital's Prime Medicine position peaked at $258K in Q1 2026.
  • 188 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.